Home » COVALENT GROUP, INC. AND SUDLER & HENNESSEY ANNOUNCE STRATEGIC PARTNERSHIP TO DESIGN AND CONDUCT GLOBAL PATIENT DISEASE REGISTRIES
COVALENT GROUP, INC. AND SUDLER & HENNESSEY ANNOUNCE STRATEGIC PARTNERSHIP TO DESIGN AND CONDUCT GLOBAL PATIENT DISEASE REGISTRIES
Covalent Group, Inc. and Sudler & Hennessey, part of the Young and Rubicam
Brands family of companies, today announced they have entered into a Strategic
Partnership for the design and conduct of Patient Disease Registries. For the
past several years, the companies have been working together on multiple projects
on an informal basis.
Genetic
Engineering News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May